New US patent for SBECD purification by CycloLab
The status of US patent application 17/344,217 (“Purification of sulfobutylated cyclodextrins with specific ion exchange resins” by CycloLab, Hungary) was
A forum for researchers, students and applicants in the field of cyclodextrin technology
The status of US patent application 17/344,217 (“Purification of sulfobutylated cyclodextrins with specific ion exchange resins” by CycloLab, Hungary) was
Remdesivir has emerged as a promising antiviral drug against SARS-CoV-2. However, data regarding the clinical benefits of remdesivir in patients
A multifunctional food packaging material (G-Eug-NPs-NF) based on gelatin nanofiber membranes (G-NF) containing eugenol nanoparticles (Eug-NPs) were prepared [1]. The
According to the global mapping of dry eye disease (DED), nearly 5 to 50 % of people suffer from DED,
SBECD polymer was prepared by crosslinking with 1,6-hexamethylene diisocyanate. Iin vitro studies were conducted on two Escherichia coli strains that differed in
Cyclodextrins (CDs) attracted increasing interest over the past few years, leading to the emergence of promising anti-tumor nanomedicines. Tackling their
In terms of solubilization effect, it was found that phase solubility of RDV increased significantly from intrinsic 1.7 mmol/L at
There were 648 patients enrolled in the study (216 cases and 432 controls). Viral clearance (VC) was observed in 490
SBECD (Captisol®) with an average degree of substitution of 6.5 sulfobutylether functional groups (SBE = 6.5), is a solubility enhancer
Lajos Szente, Ph.D., D.Sc., one of the founders and former CEO (now Scientific Advisor) of CycloLab at the company and